Agenda
| 8 a.m. | Welcome and breakfast |
| 8:10 a.m. | Keynote: The State of the Science Sethuraman “Panch” Panchanathan, former director, National Science Foundation |
| 8:50 a.m. | The Future is Here and Now: Trends in Diagnostics Market Peter Callas and Frank Hou, TD Cowen |
| 9:15 a.m. | Funding the Future: Navigating the Current Financial Landscape Amy Kelbick, senior director, McDermott+, moderator Corey Casper, chief research officer, Banner Health Donna Hochberg, head of diagnostics, Health Advances Erich Sachse, partner, Deloitte |
| 10:30 a.m. | Transformative Diagnostics: Exciting New Technologies Amit Agrawal, head of innovation, Danaher Diagnostics, moderator Alie Buckmire, CEO, ZelosDx Todd Levine, founder, CND Diagnostics Matt Mitcho, CEO, Gemelli Biotech |
| 11:30 a.m. | FDA Center for Devices and Radiological Health Update Courtney Lias, director, FDA Office of In-Vitro Diagnostic Devices |
| 12 p.m. | Lunch keynote: AI in Diagnostics — Where Are We Headed? George Poste, chief scientist and Regents Professor, Complex Adaptive Systems Initiative, ASU |
| 12:45p.m. | Scaling AI and Achieving Adoption — From Pilots to Practice Michael Donovan and Travis Schlappi, ASU College of Health Solutions, moderators Jeff Luber, CEO, Clairity Audrey Ozols, CEO, Da Vinci Health Group Laila Paszti, partner, Polsinelli Divya Pathak, chief data officer, NYC Health and Hospitals |
| 1:45 p.m. | Executive Insights: Vision and Strategy from Diagnostic Industry Leaders Michael Yudell, dean, ASU College of Health Solutions, moderator Julia Cheek, CEO and founder, Everlywell Alec Ford, CEO, Karius Bio |
| 2:45 p.m. | Call to action and closing Mara Aspinall, partner, Illumina Ventures; and professor of practice, ASU College of Health Solutions |
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.